Notice of Public Hearing (TEFRA)

NOTICE OF PUBLIC HEARING (TEFRA) (Posted November 5, 2026 at 10:00 AM)

NEW JERSEY ECONOMIC DEVELOPMENT AUTHORITY NOTICE OF PUBLIC HEARING 

TEFRA NOTICE

NEW JERSEY ECONOMIC DEVELOPMENT AUTHORITY

NOTICE OF PUBLIC HEARING

The New Jersey Economic Development Authority (the “Authority”) will hold a public hearing at its regular monthly meeting on November 16, 2026 at 10:00 a.m. at the Authority’s Board Room located at 36 West State Street, 1st Floor, Trenton, New Jersey 08625, or at 1-888-790-3708 (Conference ID: 7825427).  The public hearing will be held for the purpose of providing a reasonable opportunity for interested persons to express their views, both orally and in writing, with respect to the proposed issuance by the Authority of its Qualified 501(c)(3) Bonds, as defined in section 145 of the Internal Revenue Code of 1986, as amended (the “Code”) in one or more series of tax-exempt and/or taxable, senior and/or subordinate, fixed and/or variable interest  rates and current interest and/or capital appreciation revenue bonds (the “Bonds”) in an aggregate principal amount not to exceed $720,000,000 pursuant to a plan of financing in connection with the following matters:

CVH-Redefine, LLC, a limited liability company organized under the laws of the State of Delaware (the “Purchaser”), being a single member limited liability company that is disregarded as an entity separate from its sole member for federal income tax purposes, and the sole direct or indirect member of the Purchaser being CuraVerus Integrated Health Corporation, a Delaware nonstock corporation and an organization exempt from federal income taxes pursuant to Section 501(c)(3) of the Internal Revenue Code of 1986, as amended, has requested that the Authority issue the Bonds and lend the proceeds thereof to the Purchaser and Redefine Management LLC, a limited liability company organized under the laws of the State of New Jersey (“Redefine” and together with the Purchaser, the “Borrower”), to the Borrower to be used by the Purchaser to (a) finance and/or reimburse the costs of (1) the acquisition of a diversified, integrated network of physician practices, ambulatory surgery centers, medical office buildings, management and billing services, ancillary service lines and value-based care initiatives (either via the acquisition, directly or indirectly in a manner consistent with the restrictions on the corporate practice of medicine, of the membership interests in the entities that own such assets or through the acquisition of such assets directly), including the acquisition of all of the membership interests in Redefine Management LLC, a New Jersey limited liability company, and making funds available to CuraVerus Medical Group, P.C., a New Jersey professional corporation, for the acquisition of all of the membership interests in Premier Brain and Spine LLC, a New Jersey limited liability company, and (2) expand, renovate and/or equip certain facilities owned and operated by such entities and located in the State (collectively referred to herein as the “Project” and the boroughs, townships and communities and the Counties in which the Project are situated (as set forth in Exhibit A hereto are the “Project Municipalities”), and (b) establish a debt service reserve fund for the benefit of all or a portion of the Bonds, (c) fund certain liquidity and other reserves, (d) fund a portion of interest due on the Bonds during the transition period for the Project, (e) finance working capital, and (f) pay certain expenses incurred in connection with the issuance of the Bonds ((a) – (f), collectively, the “Financing Purposes”);

The reasonably expected $720,000,000 maximum principal amount of Bonds may be allocable to any one of the addresses listed in Exhibit A and/or any particular component of the Project, but the aggregate principal amount of Bonds allocable to all components of the Project will not exceed $720,000,000.  The Project will be owned and operated by the Borrower.

At the hearing, members of the public may appear in person or by attorney or by calling in on the Authority’s telephone conference line at 1-888-790-3708, Conference ID: 7825427 to provide information and make statements concerning the foregoing application.  Written comments must be submitted to the Authority no later than 5:00 p.m. on the day before the public hearing.  ECONOMIC DEVELOPMENT FINANCINGS OF THE NEW JERSEY ECONOMIC DEVELOPMENT AUTHORITY WILL BE SPECIAL, LIMITED OBLIGATIONS OF THE AUTHORITY PAYABLE SOLELY FROM THE PAYMENTS MADE BY THE BORROWER TO THE AUTHORITY AND CERTAIN FUNDS AND ACCOUNTS ESTABLISHED UNDER THE INDENTURE FOR THE BONDS AND ARE NOT OBLIGATIONS OF THE STATE OF NEW JERSEY, NOR OF ANY COUNTY OR MUNICIPALITY THEREOF.

            This notice is published in accordance with the public notice requirements of Section 147(f) of the Internal Revenue Code of 1986, as amended.

Exhibit A